Condition Focus: Mesenchymal Stem Cell Activation — Tissue Regeneration Capacity
Mesenchymal stem cells (MSCs) are the body’s repair workforce — multipotent cells that can differentiate into osteoblasts (bone), chondrocytes (cartilage), adipocytes (fat), and other connective tissue cell types depending on the signals they receive. In aged or chronically inflamed joints, MSC function declines, reducing the tissue’s capacity for self-repair. This systematic review from Ahrabi and colleagues synthesized 42 studies examining whether PBM can enhance MSC performance.
The answer across all 42 studies was consistently affirmative. PBM enhanced MSC proliferation (more repair cells), migration (cells moving to damage sites), and differentiation (cells becoming the specific tissue type needed). The effects were demonstrated across osteogenic, adipogenic, and chondrogenic lineages — meaning PBM supports the stem cell pathways relevant to all the connective tissues damaged by chronic gout.
The review identified 635–810 nm as the most commonly effective wavelength range, with 1–5 J/cm² as the typical energy density. Stem cell pluripotency markers (Nanog, Oct4, Sox2) were maintained or upregulated, indicating that PBM enhances stem cell function without forcing premature differentiation or exhausting the stem cell pool.
For gout, the clinical relevance is in the maintenance phase. After an acute flare resolves, the damaged joint needs to repair cartilage, rebuild bone, and restore soft tissue. MSCs are the cells that perform this work. If PBM can enhance their capacity to proliferate and differentiate, it supports the tissue repair that occurs between flares — potentially slowing the progressive joint damage that characterises chronic gout.
G.O.A.T. for Gout Alignment:
The G.O.A.T.’s 660 nm + 850 nm wavelengths span the effective range identified in this review (635–810 nm and beyond). The 4 J/cm² target fluence falls within the 1–5 J/cm² range most commonly associated with MSC enhancement. The maintenance dosing protocol (3x/week) supports the inter-flare tissue repair that MSC activation enables.
Link to original research here
Editor’s note: The wavelength-specific stem cell data is provided by Wang et al 2017, which showed that red and NIR wavelengths specifically stimulate proliferation. The osteogenic differentiation pathway is detailed in Miranda et al 2020. For the cartilage repair that MSC-derived chondrocytes perform, see Oliveira et al 2025. The bone repair pathway fed by osteogenic MSCs is reviewed in Lu et al 2024.
Related Articles
- Red (660nm) and NIR (810nm) PBM Stimulates Stem Cell Proliferation – Wang et al 2017
- PBM in Proliferation/Differentiation of Stem Cells – Miranda et al 2020
- NIR PBM Stimulates Cartilage Matrix Synthesis in Human Chondrocytes – Oliveira et al 2025
- The Role of PBM in Accelerating Bone Repair – Lu et al 2024
- PBM, Cells of Connective Tissue and Repair – Houreld et al 2022
Key Takeaways
- 42 studies confirm PBM enhances MSC proliferation, migration, and multi-lineage differentiation
- Effective across osteogenic, adipogenic, and chondrogenic lineages — all gout-relevant tissues
- 635–810 nm at 1–5 J/cm² most commonly effective — matches G.O.A.T. parameters
- Pluripotency markers maintained — PBM enhances function without exhausting stem cell reserves
Study Overview
| Study Type: | Systematic review (42 studies) |
| Wavelength(s): | 635–810 nm (most common) |
| Treatment Protocol: | 1–5 J/cm² (common range) |
| Sample Size: | 42 studies reviewed |
| Primary Outcome: | MSC proliferation↑, migration↑, differentiation↑ across lineages |
Full Citation
Ahrabi B, et al. (2020). The effect of photobiomodulation therapy on the differentiation, proliferation, and migration of mesenchymal stem cells: a systematic review. Journal of Lasers in Medical Sciences, 11(Suppl 1), S81–S89. View Publication
